| 000 | 01623 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515050138.0 | ||
| 264 | 0 | _c20070209 | |
| 008 | 200702s 0 0 eng d | ||
| 022 | _a0887-6924 | ||
| 024 | 7 |
_a10.1038/sj.leu.2404397 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTokita, K | |
| 245 | 0 | 0 |
_aChronic idiopathic myelofibrosis expressing a novel type of TEL-PDGFRB chimaera responded to imatinib mesylate therapy. _h[electronic resource] |
| 260 |
_bLeukemia _cJan 2007 |
||
| 300 |
_a190-2 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aBenzamides |
| 650 | 0 | 4 | _aChromosomes, Human, Pair 12 |
| 650 | 0 | 4 | _aChromosomes, Human, Pair 5 |
| 650 | 0 | 4 | _aChronic Disease |
| 650 | 0 | 4 | _aFatal Outcome |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImatinib Mesylate |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOncogene Proteins, Fusion _xbiosynthesis |
| 650 | 0 | 4 |
_aPiperazines _xtherapeutic use |
| 650 | 0 | 4 |
_aPrimary Myelofibrosis _xcomplications |
| 650 | 0 | 4 |
_aPyrimidines _xtherapeutic use |
| 650 | 0 | 4 | _aTranscription, Genetic |
| 650 | 0 | 4 | _aTranslocation, Genetic |
| 700 | 1 | _aMaki, K | |
| 700 | 1 | _aTadokoro, J | |
| 700 | 1 | _aNakamura, Y | |
| 700 | 1 | _aArai, Y | |
| 700 | 1 | _aSasaki, K | |
| 700 | 1 | _aEguchi-Ishimae, M | |
| 700 | 1 | _aEguchi, M | |
| 700 | 1 | _aMitani, K | |
| 773 | 0 |
_tLeukemia _gvol. 21 _gno. 1 _gp. 190-2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.leu.2404397 _zAvailable from publisher's website |
| 999 |
_c16694196 _d16694196 |
||